0

Close
 
Upcoming Allied Market Research
2023
Pharmaceutical Label Market

Pharmaceutical Label Market

by Type (Pressure-Sensitive Label, Glue-Applied Label, Sleeve Label, In-Mold Label, Others) and by Application (Instructional Label, Decorative Label, Functional Label, Promotional Label, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

MC : Advanced Materials
Report Code: A15908
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Pharmaceutical Label Market

Request Now !

A pharmaceutical label refers to a piece of paper, plastic or printed material that is used to provide instructions and product information to the consumers. It mentions the dosage instructions, expiration date, ingredients of the medicine as well as the rules and regulations that were adhered to during its manufacturing. A strategically planned pharmaceutical label assists in consistent branding, conveying critical medical data, preventing excessive regulatory penalties and creating transparent communication with the customer. In recent years, pharma companies have started using value-added labelling solutions such as labels with QR codes and RFID tags. They are also employing clear label designs to effectively communicate the product benefits to the consumers.

Market scope and Structure Analysis

Covid-19 Impact Analysis 

  • The coronavirus's unfavorable global effects are already evident, and they will have a big impact on the pharmaceutical label market in 2020.
  • The World Health Organization has declared a public health emergency after the COVID-19 virus outbreak in December 2019. The disease has spread to over 100 nations and resulted in massive deaths all across the world. Exports & Imports, global manufacturing, tourism, and financial sectors have all been heavily damaged.
  • The downward pressure on the global economy, which had previously shown signs of improvement, has escalated once more. The outbreak of the virus has added danger factors to the international economy's already sluggish development. Many international groups have stated that the global economy is experiencing its most difficult moment since the financial crisis.
  • The lockdown has resulted in hampering the imports and exports of various goods. Also, the uncertainty created in the market in the consumers’ buying pattern has resulted in hampering the pharmaceutical label market.


Top Impacting Factors

The increasing demand for pharmaceutical products owing to the rising occurrence of medical issues, especially among the growing geriatric population is among the key factors driving the global pharmaceutical labeling market. The increasing incidents of medical problems have enhanced the consumption of pharmaceutical drugs, thus leading to a significant escalation in the demand for product labeling. Furthermore, design and printing advancements have enabled organizations to promote their brands effectively by focusing on the key features of the product and reach out to the target customers. Apart from this, growing environmental awareness among consumers regarding non-biodegradable material such as plastic has encouraged the use of renewable and recyclable raw materials for labeling. This trend has further led to a boost in the investments in research and development (R&D) of eco-friendly and sustainable alternatives. In addition, the introduction of inexpensive sleeve labels has also contributed to the market growth.

Market trends

  • Growing healthcare expenditure and pharmaceutical industry in emerging economies is a key driver for the market.
  • The pharmaceutical industry is growing at a rapid pace in emerging economies. Advanced manufacturing processes, technological innovations, and increased integration of companies have resulted in rapid growth of the industry. This growth of the pharmaceutical industry is driving the pharmaceutical label market. The growth is expected to be the highest in emerging economies such as Brazil, Russia, India, and China. Increasing income levels and growing awareness about the advantages of good healthcare systems and healthier lifestyles is supporting the growth of the market in these countries. Large population and demographics factors such as growing young population and higher life expectancy are also the key drivers of this growth.
  • Rising population in various parts of the world is also helping the market expansion.
  • The increasing demand for pharmaceutical products owing to the rising occurrence of medical issues, especially among the growing geriatric population is among the key factors driving the global pharmaceutical labeling market. The increasing incidents of medical problems have enhanced the consumption of pharmaceutical drugs, thus leading to a significant escalation in the demand for product labeling.
  • Advancement in printing industry and global environmental awareness is bolstering the market growth.
  • Design and printing advancements have enabled organizations to promote their brands effectively by focusing on the key features of the product and reach out to the target customers. Apart from this, growing environmental awareness among consumers regarding non-biodegradable material such as plastic has encouraged the use of renewable and recyclable raw materials for labeling. This trend has further led to a boost in the investments in research and development (R&D) of eco-friendly and sustainable alternatives. Additionally, the introduction of inexpensive sleeve labels has also contributed to the market growth.

Key Benefits of the Report

  • This study presents the analytical depiction of the pharmaceutical label market industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the pharmaceutical label market share.
  • The current market is quantitatively analyzed to highlight pharmaceutical label market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market. 
  • The report provides a detailed pharmaceutical label market analysis based on competitive intensity and how the competition will take shape in coming years

Questions answered in the Pharmaceutical Label Market Report

  • Who are the leading market players active in the Pharmaceutical Label Market?
  • What current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What future projections would help in taking further strategic steps?
    • What is “Pharmaceutical Label Market “?
    • What does " Pharmaceutical Label Market " allow organizations to achieve?
    • Which technologies combine to make “Pharmaceutical Label Market “a critical organizational asset?
    • What is " Pharmaceutical Label Market” Market prediction in the future?
    • Who are the leading global players in the “Pharmaceutical Label Market” market?
    • What are the current trends and predicted trends?
    • What are the challenges faced in the " Pharmaceutical Label Market” Market?
    • What are the key benefits of the “Pharmaceutical Label Market “Market report?
    • What will be the anticipated growth rates for your own Pharmaceutical Label Market economy altogether and for every segment inside?
    • What are the driving factors and opportunities in the market?        

 Pharmaceutical Label Market Report Highlights

Aspects Details
By Type
  • Pressure-Sensitive Label
  • Glue-Applied Label
  • Sleeve Label
  • In-Mold Label
  • Others
By Application
  • Instructional Label
  • Decorative Label
  • Functional Label
  • Promotional Label
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (UK, Germany, France, Italy, Spain, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: PHARMACEUTICAL LABEL MARKET, BY TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Type

    • 4.2. Pressure-Sensitive Label

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Glue-Applied Label

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Sleeve Label

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. In-Mold Label

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

    • 4.6. Others

      • 4.6.1. Key Market Trends, Growth Factors and Opportunities

      • 4.6.2. Market Size and Forecast, By Region

      • 4.6.3. Market Share Analysis, By Country

  • CHAPTER 5: PHARMACEUTICAL LABEL MARKET, BY APPLICATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Application

    • 5.2. Instructional Label

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Decorative Label

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Functional Label

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Promotional Label

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

    • 5.6. Others

      • 5.6.1. Key Market Trends, Growth Factors and Opportunities

      • 5.6.2. Market Size and Forecast, By Region

      • 5.6.3. Market Share Analysis, By Country

  • CHAPTER 6: PHARMACEUTICAL LABEL MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Type

      • 6.2.3. Market Size and Forecast, By Application

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Pharmaceutical Label Market

        • 6.2.5.1. Market Size and Forecast, By Type
        • 6.2.5.2. Market Size and Forecast, By Application

      • 6.2.6. Canada Pharmaceutical Label Market

        • 6.2.6.1. Market Size and Forecast, By Type
        • 6.2.6.2. Market Size and Forecast, By Application

      • 6.2.7. Mexico Pharmaceutical Label Market

        • 6.2.7.1. Market Size and Forecast, By Type
        • 6.2.7.2. Market Size and Forecast, By Application

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Type

      • 6.3.3. Market Size and Forecast, By Application

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Pharmaceutical Label Market

        • 6.3.5.1. Market Size and Forecast, By Type
        • 6.3.5.2. Market Size and Forecast, By Application

      • 6.3.6. Germany Pharmaceutical Label Market

        • 6.3.6.1. Market Size and Forecast, By Type
        • 6.3.6.2. Market Size and Forecast, By Application

      • 6.3.7. Italy Pharmaceutical Label Market

        • 6.3.7.1. Market Size and Forecast, By Type
        • 6.3.7.2. Market Size and Forecast, By Application

      • 6.3.8. Spain Pharmaceutical Label Market

        • 6.3.8.1. Market Size and Forecast, By Type
        • 6.3.8.2. Market Size and Forecast, By Application

      • 6.3.9. UK Pharmaceutical Label Market

        • 6.3.9.1. Market Size and Forecast, By Type
        • 6.3.9.2. Market Size and Forecast, By Application

      • 6.3.10. Russia Pharmaceutical Label Market

        • 6.3.10.1. Market Size and Forecast, By Type
        • 6.3.10.2. Market Size and Forecast, By Application

      • 6.3.11. Rest Of Europe Pharmaceutical Label Market

        • 6.3.11.1. Market Size and Forecast, By Type
        • 6.3.11.2. Market Size and Forecast, By Application

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Type

      • 6.4.3. Market Size and Forecast, By Application

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Pharmaceutical Label Market

        • 6.4.5.1. Market Size and Forecast, By Type
        • 6.4.5.2. Market Size and Forecast, By Application

      • 6.4.6. Japan Pharmaceutical Label Market

        • 6.4.6.1. Market Size and Forecast, By Type
        • 6.4.6.2. Market Size and Forecast, By Application

      • 6.4.7. India Pharmaceutical Label Market

        • 6.4.7.1. Market Size and Forecast, By Type
        • 6.4.7.2. Market Size and Forecast, By Application

      • 6.4.8. South Korea Pharmaceutical Label Market

        • 6.4.8.1. Market Size and Forecast, By Type
        • 6.4.8.2. Market Size and Forecast, By Application

      • 6.4.9. Australia Pharmaceutical Label Market

        • 6.4.9.1. Market Size and Forecast, By Type
        • 6.4.9.2. Market Size and Forecast, By Application

      • 6.4.10. Thailand Pharmaceutical Label Market

        • 6.4.10.1. Market Size and Forecast, By Type
        • 6.4.10.2. Market Size and Forecast, By Application

      • 6.4.11. Malaysia Pharmaceutical Label Market

        • 6.4.11.1. Market Size and Forecast, By Type
        • 6.4.11.2. Market Size and Forecast, By Application

      • 6.4.12. Indonesia Pharmaceutical Label Market

        • 6.4.12.1. Market Size and Forecast, By Type
        • 6.4.12.2. Market Size and Forecast, By Application

      • 6.4.13. Rest of Asia Pacific Pharmaceutical Label Market

        • 6.4.13.1. Market Size and Forecast, By Type
        • 6.4.13.2. Market Size and Forecast, By Application

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Type

      • 6.5.3. Market Size and Forecast, By Application

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Pharmaceutical Label Market

        • 6.5.5.1. Market Size and Forecast, By Type
        • 6.5.5.2. Market Size and Forecast, By Application

      • 6.5.6. South Africa Pharmaceutical Label Market

        • 6.5.6.1. Market Size and Forecast, By Type
        • 6.5.6.2. Market Size and Forecast, By Application

      • 6.5.7. Saudi Arabia Pharmaceutical Label Market

        • 6.5.7.1. Market Size and Forecast, By Type
        • 6.5.7.2. Market Size and Forecast, By Application

      • 6.5.8. UAE Pharmaceutical Label Market

        • 6.5.8.1. Market Size and Forecast, By Type
        • 6.5.8.2. Market Size and Forecast, By Application

      • 6.5.9. Argentina Pharmaceutical Label Market

        • 6.5.9.1. Market Size and Forecast, By Type
        • 6.5.9.2. Market Size and Forecast, By Application

      • 6.5.10. Rest of LAMEA Pharmaceutical Label Market

        • 6.5.10.1. Market Size and Forecast, By Type
        • 6.5.10.2. Market Size and Forecast, By Application

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning,2022

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. Company 1

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Company 2

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Company 3

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. Company 4

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. Company 5

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. Company 6

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. Company 7

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. Company 8

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. Company 9

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Company 10

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL PHARMACEUTICAL LABEL MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL PHARMACEUTICAL LABEL MARKET FOR PRESSURE-SENSITIVE LABEL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL PHARMACEUTICAL LABEL MARKET FOR GLUE-APPLIED LABEL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL LABEL MARKET FOR SLEEVE LABEL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL LABEL MARKET FOR IN-MOLD LABEL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL PHARMACEUTICAL LABEL MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL PHARMACEUTICAL LABEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL LABEL MARKET FOR INSTRUCTIONAL LABEL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL LABEL MARKET FOR DECORATIVE LABEL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL LABEL MARKET FOR FUNCTIONAL LABEL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL LABEL MARKET FOR PROMOTIONAL LABEL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL LABEL MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. GLOBAL PHARMACEUTICAL LABEL MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. NORTH AMERICA PHARMACEUTICAL LABEL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. NORTH AMERICA PHARMACEUTICAL LABEL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 16. NORTH AMERICA PHARMACEUTICAL LABEL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 17. U.S. PHARMACEUTICAL LABEL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 18. U.S. PHARMACEUTICAL LABEL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 19. CANADA PHARMACEUTICAL LABEL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 20. CANADA PHARMACEUTICAL LABEL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 21. MEXICO PHARMACEUTICAL LABEL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 22. MEXICO PHARMACEUTICAL LABEL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 23. EUROPE PHARMACEUTICAL LABEL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 24. EUROPE PHARMACEUTICAL LABEL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 25. EUROPE PHARMACEUTICAL LABEL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 26. FRANCE PHARMACEUTICAL LABEL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 27. FRANCE PHARMACEUTICAL LABEL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 28. GERMANY PHARMACEUTICAL LABEL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 29. GERMANY PHARMACEUTICAL LABEL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 30. ITALY PHARMACEUTICAL LABEL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 31. ITALY PHARMACEUTICAL LABEL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 32. SPAIN PHARMACEUTICAL LABEL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 33. SPAIN PHARMACEUTICAL LABEL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 34. UK PHARMACEUTICAL LABEL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 35. UK PHARMACEUTICAL LABEL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 36. RUSSIA PHARMACEUTICAL LABEL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 37. RUSSIA PHARMACEUTICAL LABEL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 38. REST OF EUROPE PHARMACEUTICAL LABEL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 39. REST OF EUROPE PHARMACEUTICAL LABEL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 40. ASIA-PACIFIC PHARMACEUTICAL LABEL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 41. ASIA-PACIFIC PHARMACEUTICAL LABEL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 42. ASIA-PACIFIC PHARMACEUTICAL LABEL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 43. CHINA PHARMACEUTICAL LABEL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 44. CHINA PHARMACEUTICAL LABEL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 45. JAPAN PHARMACEUTICAL LABEL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 46. JAPAN PHARMACEUTICAL LABEL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 47. INDIA PHARMACEUTICAL LABEL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 48. INDIA PHARMACEUTICAL LABEL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 49. SOUTH KOREA PHARMACEUTICAL LABEL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 50. SOUTH KOREA PHARMACEUTICAL LABEL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 51. AUSTRALIA PHARMACEUTICAL LABEL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 52. AUSTRALIA PHARMACEUTICAL LABEL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 53. THAILAND PHARMACEUTICAL LABEL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 54. THAILAND PHARMACEUTICAL LABEL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 55. MALAYSIA PHARMACEUTICAL LABEL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 56. MALAYSIA PHARMACEUTICAL LABEL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 57. INDONESIA PHARMACEUTICAL LABEL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 58. INDONESIA PHARMACEUTICAL LABEL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 59. REST OF ASIA PACIFIC PHARMACEUTICAL LABEL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 60. REST OF ASIA PACIFIC PHARMACEUTICAL LABEL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 61. LAMEA PHARMACEUTICAL LABEL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 62. LAMEA PHARMACEUTICAL LABEL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 63. LAMEA PHARMACEUTICAL LABEL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 64. BRAZIL PHARMACEUTICAL LABEL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 65. BRAZIL PHARMACEUTICAL LABEL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 66. SOUTH AFRICA PHARMACEUTICAL LABEL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 67. SOUTH AFRICA PHARMACEUTICAL LABEL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 68. SAUDI ARABIA PHARMACEUTICAL LABEL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 69. SAUDI ARABIA PHARMACEUTICAL LABEL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 70. UAE PHARMACEUTICAL LABEL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 71. UAE PHARMACEUTICAL LABEL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 72. ARGENTINA PHARMACEUTICAL LABEL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 73. ARGENTINA PHARMACEUTICAL LABEL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 74. REST OF LAMEA PHARMACEUTICAL LABEL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 75. REST OF LAMEA PHARMACEUTICAL LABEL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 76. COMPANY 1: KEY EXECUTIVES
  • TABLE 77. COMPANY 1: COMPANY SNAPSHOT
  • TABLE 78. COMPANY 1: OPERATING SEGMENTS
  • TABLE 79. COMPANY 1: PRODUCT PORTFOLIO
  • TABLE 80. COMPANY 1: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 81. COMPANY 2: KEY EXECUTIVES
  • TABLE 82. COMPANY 2: COMPANY SNAPSHOT
  • TABLE 83. COMPANY 2: OPERATING SEGMENTS
  • TABLE 84. COMPANY 2: PRODUCT PORTFOLIO
  • TABLE 85. COMPANY 2: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 86. COMPANY 3: KEY EXECUTIVES
  • TABLE 87. COMPANY 3: COMPANY SNAPSHOT
  • TABLE 88. COMPANY 3: OPERATING SEGMENTS
  • TABLE 89. COMPANY 3: PRODUCT PORTFOLIO
  • TABLE 90. COMPANY 3: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 91. COMPANY 4: KEY EXECUTIVES
  • TABLE 92. COMPANY 4: COMPANY SNAPSHOT
  • TABLE 93. COMPANY 4: OPERATING SEGMENTS
  • TABLE 94. COMPANY 4: PRODUCT PORTFOLIO
  • TABLE 95. COMPANY 4: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 96. COMPANY 5: KEY EXECUTIVES
  • TABLE 97. COMPANY 5: COMPANY SNAPSHOT
  • TABLE 98. COMPANY 5: OPERATING SEGMENTS
  • TABLE 99. COMPANY 5: PRODUCT PORTFOLIO
  • TABLE 100. COMPANY 5: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 101. COMPANY 6: KEY EXECUTIVES
  • TABLE 102. COMPANY 6: COMPANY SNAPSHOT
  • TABLE 103. COMPANY 6: OPERATING SEGMENTS
  • TABLE 104. COMPANY 6: PRODUCT PORTFOLIO
  • TABLE 105. COMPANY 6: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 106. COMPANY 7: KEY EXECUTIVES
  • TABLE 107. COMPANY 7: COMPANY SNAPSHOT
  • TABLE 108. COMPANY 7: OPERATING SEGMENTS
  • TABLE 109. COMPANY 7: PRODUCT PORTFOLIO
  • TABLE 110. COMPANY 7: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 111. COMPANY 8: KEY EXECUTIVES
  • TABLE 112. COMPANY 8: COMPANY SNAPSHOT
  • TABLE 113. COMPANY 8: OPERATING SEGMENTS
  • TABLE 114. COMPANY 8: PRODUCT PORTFOLIO
  • TABLE 115. COMPANY 8: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 116. COMPANY 9: KEY EXECUTIVES
  • TABLE 117. COMPANY 9: COMPANY SNAPSHOT
  • TABLE 118. COMPANY 9: OPERATING SEGMENTS
  • TABLE 119. COMPANY 9: PRODUCT PORTFOLIO
  • TABLE 120. COMPANY 9: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 121. COMPANY 10: KEY EXECUTIVES
  • TABLE 122. COMPANY 10: COMPANY SNAPSHOT
  • TABLE 123. COMPANY 10: OPERATING SEGMENTS
  • TABLE 124. COMPANY 10: PRODUCT PORTFOLIO
  • TABLE 125. COMPANY 10: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL PHARMACEUTICAL LABEL MARKET SEGMENTATION
  • FIGURE 2. GLOBAL PHARMACEUTICAL LABEL MARKET
  • FIGURE 3. SEGMENTATION PHARMACEUTICAL LABEL MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN PHARMACEUTICAL LABEL MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALPHARMACEUTICAL LABEL MARKET
  • FIGURE 11. PHARMACEUTICAL LABEL MARKET SEGMENTATION, BY BY TYPE
  • FIGURE 12. PHARMACEUTICAL LABEL MARKET FOR PRESSURE-SENSITIVE LABEL, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. PHARMACEUTICAL LABEL MARKET FOR GLUE-APPLIED LABEL, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. PHARMACEUTICAL LABEL MARKET FOR SLEEVE LABEL, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. PHARMACEUTICAL LABEL MARKET FOR IN-MOLD LABEL, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. PHARMACEUTICAL LABEL MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. PHARMACEUTICAL LABEL MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 18. PHARMACEUTICAL LABEL MARKET FOR INSTRUCTIONAL LABEL, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. PHARMACEUTICAL LABEL MARKET FOR DECORATIVE LABEL, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 20. PHARMACEUTICAL LABEL MARKET FOR FUNCTIONAL LABEL, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 21. PHARMACEUTICAL LABEL MARKET FOR PROMOTIONAL LABEL, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 22. PHARMACEUTICAL LABEL MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 23. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 24. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 25. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 26. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 27. COMPETITIVE DASHBOARD
  • FIGURE 28. COMPETITIVE HEATMAP: PHARMACEUTICAL LABEL MARKET
  • FIGURE 29. Top player positioning, 2022
  • FIGURE 30. COMPANY 1: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 31. COMPANY 1: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 32. COMPANY 1: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 33. COMPANY 2: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 34. COMPANY 2: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 35. COMPANY 2: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 36. COMPANY 3: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 37. COMPANY 3: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 38. COMPANY 3: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 39. COMPANY 4: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 40. COMPANY 4: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 41. COMPANY 4: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 42. COMPANY 5: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 43. COMPANY 5: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 44. COMPANY 5: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 45. COMPANY 6: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 46. COMPANY 6: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 47. COMPANY 6: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 48. COMPANY 7: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 49. COMPANY 7: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 50. COMPANY 7: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 51. COMPANY 8: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 52. COMPANY 8: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 53. COMPANY 8: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 54. COMPANY 9: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 55. COMPANY 9: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 56. COMPANY 9: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 57. COMPANY 10: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 58. COMPANY 10: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 59. COMPANY 10: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now
RELATED TAGS

Purchase Full Report of
Pharmaceutical Label Market

Start reading.
This Report and over 68,246+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers